ClinicalTrials.Veeva

Menu

Effect of Perioperative Hemodynamic Optimization on the Immune Function Parameters of Peripheral Blood Monocytes After Cardiac Surgery (Algebra)

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status

Unknown

Conditions

Postoperative Outcome
Postoperative Wound Infection

Treatments

Device: Pulse contour cardiac output device

Study type

Interventional

Funder types

Other

Identifiers

NCT01184430
Algebra

Details and patient eligibility

About

Cardiac surgery patients have a high risk to suffer from postoperative infections. Some studies have shown, that humoral and cellular factors are associated with perioperative immunodysfunction and can increase the risk of postoperative infections. Monocytes in the blood and, especially alveolar macrophages are important for an adequate host defence. In studies the investigators have shown that hemodynamic parameters have a significant influence on the probability to develop postoperative infections. The aim of the study is to investigate, whether cardiac surgery patients have an altered immune function after surgery that is predictive for the latter development of subsequent infections and whether they benefit from a goal-directed volume and hemodynamic therapy.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • elective cardiac surgery patient undergoing cardiopulmonary bypass
  • signed informed consent

Exclusion criteria

  • pregnant or breast feeding women
  • Age <18 years
  • pulmonary disease with an oxygenation index <300mmHg
  • liver disease (>Child B)
  • HIV-Infection
  • Therapy with corticosteroids
  • Condition after transplantation
  • preexisting infection before operation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

advanced hemodynamic monitoring
Active Comparator group
Description:
advanced hemodynamic monitoring with pulse contour analysis ( LiDCO rapid) and goal-directed therapy
Treatment:
Device: Pulse contour cardiac output device
standard monitoring
No Intervention group
Description:
hemodynamic monitoring based on the standard operating procedures of our clinic

Trial contacts and locations

1

Loading...

Central trial contact

Katharina Berger, MD; Michael Sander, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems